Trulieve Cannabis CTO reports RSU tax-share withholding

Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer.

Rhea-AI Filing Summary

Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer. On December 1, 2025, 18,041 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax withholding, the reporting person beneficially owns 180,660 subordinate voting shares directly and an additional 7,000 shares indirectly through a spouse. This filing reflects a routine administrative adjustment related to equity compensation rather than an open-market trade.

Insider Trade Summary

Exercise Price or Tax Liability: 18,041 shares

Exercise Price or Tax Liability 2 txns

Insider Jhala Nilyum

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Subordinate Voting Shares	18,041	$5.39	$97K
holding	Subordinate Voting Shares	--	--	--

Holdings After Transaction: Subordinate Voting Shares — 180,660 shares (Direct); Subordinate Voting Shares — 7,000 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Trulieve Cannabis Corp. (TCNNF) report in this Form 4?

The Chief Technology Officer reported 18,041 subordinate voting shares withheld to satisfy tax liability related to the vesting of previously granted restricted stock units on December 1, 2025.

Did the Trulieve Cannabis (TCNNF) CTO buy or sell shares on the open market?

No open-market purchase or sale is reported. The 18,041 shares were withheld by the company to cover taxes owed upon RSU vesting, which is an administrative transaction.

How many Trulieve Cannabis (TCNNF) shares does the CTO own after this transaction?

Following the tax withholding, the CTO beneficially owns 180,660 subordinate voting shares directly and 7,000 shares indirectly through a spouse.

What does transaction code "F" mean in the Trulieve Cannabis (TCNNF) Form 4?

Transaction code "F" indicates shares were withheld by the issuer to pay taxes due on the vesting or exercise of equity awards, in this case restricted stock units.

Why were Trulieve Cannabis (TCNNF) RSU-related shares withheld at $5.39?

The 18,041 shares were valued at $5.39 per share for the purpose of determining the amount withheld to satisfy the reporting person’s tax liability tied to RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 04:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jhala Nilyum

(Last) (First) (Middle)

6749 BEN BOSTIC ROAD

(Street)

QUINCY FL 32351

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	12/01/2025		F		18,041(1)	D	$5.39	180,660	D
Subordinate Voting Shares								7,000	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4.

	/s/ Eric Powers, as Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.